Wednesday, January 29, 2020

 


Aequus Pharmaceuticals Inc
(OTHER OTC: AQSZF) Add to Watchlist
$0.1078
+0.0078 (+7.80%)
as of Jan 28, 2020

Last 0.1078
Change +0.0078 (+7.80%)
Open 0.1024
Prev. Close 0.1000
Today's Range
0.0937 0.1078
52wk Range
0.0590 0.1847
Volume 26,400
Avg Volume 60,195
Sector All Sectors By Industry

Recent Headlines
Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to announce that a major health authority in British Columbia recently announced a change to  (full story)
AQS.VN: 0.135 (unch), AQSZF: 0.1078 (+0.0078)
Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to announce that it has advanced the filings for provincial reimbursement in both Quebec and  (full story)
AQS.VN: 0.135 (unch), AQSZF: 0.1078 (+0.0078)
Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to announce the signing of a term sheet to co-commercialize a portfolio of products in the US  (full story)
AQS.VN: 0.135 (unch), AQSZF: 0.1078 (+0.0078)
Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the three months ended September 30, 2019 ("Q3 2019") and associate  (full story)
AQS.VN: 0.135 (unch), AQSZF: 0.1078 (+0.0078)
Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company") today acknowledged the research results presented at the American Academy of Ophthalmology in San Francisco that revealed bimatoprost 0.03%, branded as Vistitan and promoted by Aequus in Canada, as the most efficacio  (full story)
AQS.VN: 0.135 (unch), AQSZF: 0.1078 (+0.0078)
Performance Comparison
Name Today 3-Month 1-Year
AQSZF +7.80% +7.80% -25.66%
DJIA +0.66% +3.38% +17.10%
S&P 500 +1.01% +5.89% +23.92%

Key Statistics
Annual EPS --
Dividend & Yield -- (--)
P/E Ratio N/A
Market Capitalization, $K --
Weighted Alpha -13.54
Standard Deviation +0.70
Profit Margin --
Beta N/A

Growth Rates
YTD +15.67%
1-Year -21.31%
3-Year -52.70%
© 2020 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.